Close Menu

NEW YORK — Molecular diagnostics firm OpGen on Tuesday said it has signed a definite agreement to sell $10 million in stock and warrants to an unnamed US-based healthcare-focused institutional investor.

Through the private placement, OpGen would sell 2,245,400 shares of its common stock and an equal number of common warrants to purchase an additional 2,245,400 shares. Additionally, the company would sell 2,597,215 prefunded warrants, each exercisable for one share of common stock, and 2,597,215 common warrants to purchase up to the same number of shares of common stock.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.